
Complement 1 Secures $16M Seed Round to Scale Clinically
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) — Complement 1, a health tech startup transforming cancer care through personalized lifestyle medicine, today announced a $16 million oversubscribed seed funding round led by Owl Ventures and Blume Ventures. The company is emerging from stealth to launch the first tech-enabled, clinically validated lifestyle modification platform for cancer…